Yubo Zhou

4.1k citations
171 papers · 2.8k indexed · h-index 28
Topics
Protein Degradation and Inhibitors (46 papers)Ubiquitin and proteasome pathways (37 papers)Histone Deacetylase Inhibitors Research (23 papers)
Journals
Angewandte Chemie International EditionNature CommunicationsSHILAP Revista de lepidopterología
Partner nations
ChinaUnited StatesNorway

In The Last Decade

Yubo Zhou

156 papers receiving 2.8k citations

Peers

Yubo Zhou
Comparison fields: 5 of 127
  • Molecular Biology 1.7k
  • Organic Chemistry 755
  • Oncology 469
  • Cancer Research 217
  • Pharmacology 203
Replace Chuan Shih with:
Chuan Shih United States
Jérôme Kluza France
Chris P. Miller United States
Gyoonhee Han South Korea
Daniela M. Zisterer Ireland
Zhang Zhang China
Shiow‐Lin Pan Taiwan
Parvez Κhan India
Philip Reigan United States
Jinyun Dong China
Yubo Zhou relative to Chuan Shih United States Chuan Shih's profile →
Citations per field
00.5×5.7×
Chuan Shih · 1×
Citations per year

Countries citing papers authored by Yubo Zhou

Since Specialization
Citations

This map shows the geographic impact of Yubo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubo Zhou more than expected).

Fields of papers citing papers by Yubo Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubo Zhou. The network helps show where Yubo Zhou may publish in the future.

Co-authorship network of co-authors of Yubo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yubo Zhou. A scholar is included among the top collaborators of Yubo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubo Zhou. Yubo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 0
5 0
6 9
7 3
8 2
9 0
10 1
11 9
12 4
13 3
14 2
15 2
16 5
17 31
18 15
19 4
20 5

About Yubo Zhou

Yubo Zhou is a scholar working on Toxicology, Hematology and Molecular Biology, having authored 171 papers that have together received 2.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (46 papers), Ubiquitin and proteasome pathways (37 papers) and Histone Deacetylase Inhibitors Research (23 papers). The work is most often cited by research in Toxicology (117 citations), Organic Chemistry (755 citations) and Molecular Biology (1.7k citations). Yubo Zhou has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Jia Li, Jingchun Sun, Qi Liu, Hua Xu, Qiang Wei, Jingqi Wang, Xuefeng Jiang, Mingbo Su, Lei Xu and Deqing Hu. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026